Synergy Pharmaceuticals, Inc.
(NASDAQ : SGYP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
0.61%19.912.0%$687.78m
SHPGShire PLC Sponsored ADR
-1.31%174.300.4%$143.17m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.61%137.416.8%$104.28m
PRGOPerrigo Co. Plc
0.70%71.746.8%$101.79m
ENDPEndo International Plc
-0.14%18.048.9%$71.21m
JAZZJazz Pharmaceuticals Plc
-0.41%156.602.2%$65.88m
MNKMallinckrodt Plc
-2.13%26.6621.1%$52.21m
SAGESAGE Therapeutics, Inc.
-0.04%117.839.6%$48.23m
ICPTIntercept Pharmaceuticals, Inc.
-2.24%89.9418.7%$43.97m
UTHRUnited Therapeutics Corporation
-1.34%120.6314.4%$36.23m
ICLRICON Plc
-2.75%139.154.1%$33.05m
CTLTCatalent Inc
-2.20%40.422.4%$29.10m
MDCOMedicines Company
-2.26%25.9921.8%$27.72m
AERIAerie Pharmaceuticals, Inc.
-0.67%57.736.9%$27.34m
PTLAPortola Pharmaceuticals, Inc.
-1.29%20.737.7%$25.95m

Company Profile

Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.